A detailed history of Brewin Dolphin Wealth Management LTD transactions in Dexcom Inc stock. As of the latest transaction made, Brewin Dolphin Wealth Management LTD holds 1,820 shares of DXCM stock, worth $135,517. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,820
Previous 455 300.0%
Holding current value
$135,517
Previous $233,000 41.63%
% of portfolio
0.01%
Previous 0.03%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Nov 14, 2022

BUY
$67.99 - $132.89 $92,806 - $181,394
1,365 Added 300.0%
1,820 $136,000
Q4 2021

Nov 14, 2022

BUY
$129.87 - $162.82 $59,090 - $74,083
455 New
455 $244,000
Q3 2020

Nov 09, 2023

SELL
$95.51 - $112.95 $6,303 - $7,454
-66 Reduced 12.67%
455 $188 Million
Q2 2020

Nov 09, 2023

SELL
$62.68 - $105.34 $81,421 - $136,836
-1,299 Reduced 71.37%
521 $211 Million
Q1 2020

Nov 09, 2023

SELL
$47.79 - $75.63 $83,823 - $132,655
-1,754 Reduced 96.37%
66 $17.8 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $28.8B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Brewin Dolphin Wealth Management LTD Portfolio

Follow Brewin Dolphin Wealth Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brewin Dolphin Wealth Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Brewin Dolphin Wealth Management LTD with notifications on news.